Washington recalls
3,453 federal recalls affecting Washington in the last 12 months - 259 Washington-specific plus 3,194 nationwide. Sourced from CPSC, FDA, USDA, and NHTSA.
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concern
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Digi Eye recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Max Strength recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops Max Strength recalled for sterility risk
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugRohto-MentholatumClass IINationwideRohto Cooling Eye Drops recalled for sterility concerns
Lack of Assurance of Sterility
- 2026-07-29FDA-DrugAscend LaboratoriesClass IINationwideAscend amlodipine-olmesartan tablets recalled for low drug content
Failed Dissolution Specifications; Olmesartan Medoxomil content below specifications
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine 125 mcg recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for low potency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine recalled for reduced potency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine 112 mcg recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals Levothyroxine Sodium Tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for reduced potency
Subpotent Drug
- 2026-07-29FDA-DrugMajor PharmaceuticalsClass IINationwideMajor Pharmaceuticals levothyroxine tablets recalled for subpotency
Subpotent Drug
- 2026-07-29FDA-DrugPrecision DoseNot Yet ClassifiedNationwidePrecision Dose glycopyrrolate solution recalled for impurity
Due to an out-of-specification result for an unidentified impurity detected during routine stability testing.
- 2026-07-29FDA-PR529 CommerceNationwideRooted in Rare Aquafaba Powder recalled for undeclared egg
529 Commerce, LLC of Parkland, Florida is recalling 3,860 units of its 4oz and 12 oz packages of its Rooted in Rare brand Aquafaba Powder because the product may contain undeclared egg. People who have an allergy or severe sensitivity to egg run the risk of serious or life-threatening allergic reac
- 2026-07-24FDA-PRSunny PharmtechNationwideSunny Pharmtech Cyclophosphamide recalled for steel particles
July 24, 2026 - Taoyuan City, Taiwan - Sunny Pharmtech, Inc is voluntarily recalling three lots of Cyclophosphamide for Injection, USP, 1g/vial and 2g/vial, to the User Level due to the presence of particulate matter identified as steel. To date, no adverse events or injuries associated with this pa
- 2026-07-24FDA-PRBaxterNationwideBaxter Cefazolin Dextrose Injection recalled for particulate contamination
July 24, 2026 – DEERFIELD, Ill., Baxter International Inc. (NYSE:BAX) is voluntarily recalling Lot LD175708, Exp 14-Feb 2027 of Cefazolin in Dextrose Injection due to a report of particulate matter found in the solution identified as cardboard.<br> Risk Statement: The use of the defective product has a
- 2026-07-24FDA-PRAmerican RegentNationwideAmerican Regent Papaverine Injection recalled for glass particles
July 24, 2026 – Shirley, NY, American Regent, Inc. is conducting a nationwide voluntary recall of a single lot of Papaverine Hydrochloride Injection, USP, 60 mg/2 mL single dose vial to the consumer level. The product is being recalled due to the presence of particulate matter identified as glass an
- 2026-07-24USDARoyale NaturalClass IMaple Leaf Foods bacon recalled for import violation
Import Violation
- 2026-07-23CPSCPeony DesignNationwidePeony Design baby bibs and stroller bags recalled for choking hazard
The snap can detach from the recalled bibs and stroller bags, posing a risk of serious injury or death from a choking hazard to young children.
- 2026-07-23CPSCYouRfocusNationwideCuddleCubs Creations teething toys recalled for choking risk
The recalled teething toy sets contain a pull string teething toy that violates the mandatory standard for toys because the silicone strings are smaller and longer than permitted. The strings can reach the back of a child's throat and become lodged, posing a risk of respiratory distress and a deadly choking hazard.
- 2026-07-23CPSCYuanxinxiangNationwideOeyUoc pool drain covers recalled for drowning risk
The recalled drain covers violate the entrapment protection standards of the Virginia Graeme Baker Pool and Spa Safety Act (VGBA), posing deadly entrapment and drowning hazards to consumers.
- 2026-07-23CPSCSviyatpNationwideSviyatp pool drain covers recalled for entrapment risk
The recalled drain covers violate the entrapment protection standards of the Virginia Graeme Baker Pool and Spa Safety Act (VGBA), posing deadly entrapment and drowning hazards to consumers.
- 2026-07-23CPSCSegmartNationwideAojieni Silicone teething toys recalled for choking risk
The recalled teething toys violate the mandatory standard for toys because the silicone strings are smaller and longer than permitted. The strings can reach the back of children's throat and become lodged, posing a serious risk of respiratory distress and deadly choking hazard.
Get notified about new Washington recalls
Free weekly digest. Add Washington to your profile to filter alerts to your state.
Get the Sunday Brief